Binney Street Capital/Dana-Farber Cancer Institute is Dana-Farber Cancer Institute's Boston-based venture fund, backing U.S. companies that leverage Dana-Farber technologies or expertise. It focuses on life sciences, biotechnology, oncology therapeutics and diagnostics, with broader health and pharmaceutical opportunities where the Institute can add clinical and research insight. The fund invests from company creation through early clinical validation and has also participated in later-stage venture financings.